20.03.2015 • NewsAir LiquideBASFDede Willams

BASF Chooses Freeport for World-Scale Methanol Complex

BASF has selected Freeport, Texas, as the potential site for its planned 475,000 t/y world-scale methane-to-propylene complex on the US Gulf Coast.

The facility will use Air Liquide's Lurgi MegaMethanol and Methanol-to-Propylene (MTP) technologies, and the French gases producer will provide basic engineering services for the complex.

The project, BASF's largest single-plant investment to date, is subject to final approval in 2016 by the German group's managing board.

The Freeport site was founded in 1958 as the first BASF manufacturing facility outside of Europe. With more than 800 full-time employees, it is one of two of the German group's two integrated sites in North America.

On-purpose production of propylene to supply its North American operations would allow BASF to take advantage of low gas prices resulting from US shale gas production, the group said, adding that the investment would further strengthen its backward integration into propylene and grow its propylene-based downstream activities, leading to a stronger market position in North America.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.